Chemours (CC) Tops Q4 EPS by 20c

Chemours (NYSE: CC) reported Q4 EPS of $0.61, $0.20 better than the analyst estimate of $0.41. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.28 billion.

GUIDANCE:

Chemours sees FY2021 EPS of $2.40-$3.12, versus the consensus of $2.60.

For earnings history and earnings-related data on Chemours (CC) click here.

You May Also Be Interested In

• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• NY AG sues 3M, DuPont, and others over PFAS pollution in New York